Want to join the conversation?
$VRX said it has restored net profitability to new dermatology prescriptions starting on Aug. 5, 2016, which will improve the overall derm selling price. The company launched a new prior authorization process with its partner Walgreens on Aug.4, which should improve the adjudication experience.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.